Skip to main content
Year archive

BioPorto — 2019 filings

All 37 regulatory filings released by BioPorto (BIOPOR) in 2019, sourced directly from the official regulator.

37 Filings
2019 Period
2019 filings (37)
Filing Released Lang
BioPorto to provide additional patient information in support of its US application for regulatory clearance of The NGAL Test™ for pediatric risk assessment of Acute Kidney Injury
Regulatory Filings
2019-11-18 English
Regulatory Filings 2019
Regulatory Filings
2019-11-18 English
BioPorto submits answers to the FDA regarding The NGAL Test™ for risk assessment for AKI in pediatric patients
Regulatory Filings
2019-10-17 English
BioPorto submits answers to the FDA regarding The NGAL Test™ for risk assessment for AKI in pediatric patients
Regulatory Filings
2019-10-17 English
Regulatory Filings 2019
Regulatory Filings
2019-10-17 English
Updated Financial calendar for 2019 and Financial calendar for 2020
Report Publication Announcement
2019-09-06 English
Updated Financial calendar for 2019 and Financial calendar for 2020
Report Publication Announcement
2019-09-06 English
Updated Financial calendar for 2019 and Financial calendar for 2020
Report Publication Announcement
2019-09-06 English
Updated Financial calendar for 2019 and Financial calendar for 2020
Report Publication Announcement
2019-09-06 English
Grant of warrants
Capital/Financing Update
2019-08-15 English
Grant of warrants
Capital/Financing Update
2019-08-15 English
Grant of warrants
Capital/Financing Update
2019-08-15 English
Grant of warrants
Remuneration Information
2019-08-15 English
BioPorto A/S - Extraordinary General Meeting
Declaration of Voting Results & Voting Rights Announcements
2019-08-15 English
BioPorto A/S - Extraordinary General Meeting
Declaration of Voting Results & Voting Rights Announcements
2019-08-15 English
BioPorto A/S - Extraordinary General Meeting
Declaration of Voting Results & Voting Rights Announcements
2019-08-15 English
BioPorto A/S - Extraordinary General Meeting
Board/Management Information
2019-08-15 English
BioPorto Announces Q2 2019 Report
Interim / Quarterly Report Q2 2019
2019-08-15 English
BioPorto Announces Q2 2019 Report
Interim / Quarterly Report Q2 2019
2019-08-15 English
BioPorto Announces Q2 2019 Report
Interim / Quarterly Report Q2 2019
2019-08-15 English
BioPorto Announces Q2 2019 Report
Interim / Quarterly Report Q2 2019
2019-08-15 English
BioPorto Announces Q2 2019 Report
Report Publication Announcement Q2 2019
2019-08-15 English
Interim / Quarterly Report 2019
Interim / Quarterly Report H1 2019
2019-08-15 English
Legal Proceedings Report 2019
Legal Proceedings Report
2019-07-13 English
BioPorto to redraw U.S. application for regulatory clearance of The NGAL Test™ for risk assessment for AKI in patients under the age of 22 with the intend to resubmit in Q4 2019
Regulatory Filings
2019-07-13 English
Adjustment of timeline for FDA decision regarding application for pediatric clinical use of The NGAL Test™
Regulatory Filings
2019-07-02 English
Regulatory Filings 2019
Regulatory Filings
2019-07-02 English
Changes in number of shares and votes
Share Issue/Capital Change
2019-06-28 English
Changes in number of shares and votes
Share Issue/Capital Change
2019-06-28 English
BioPorto A/S to Increase its Share Capital through a Cash Issue, Private Placement
Share Issue/Capital Change
2019-06-17 English
Capital/Financing Update 2019
Capital/Financing Update
2019-06-17 English
BioPorto Submits Pediatric Application to FDA for The NGAL Test™ Under Breakthrough Designation
Regulatory Filings
2019-05-15 English
Legal Proceedings Report 2019
Legal Proceedings Report
2019-05-15 English
BioPorto Appoints New President of BioPorto Diagnostics, Inc.
Board/Management Information
2019-04-15 English
Report Publication Announcement 2019
Report Publication Announcement
2019-02-22 English
Annual Report 2018
Annual Report FY 2018
2019-02-22 English
BioPorto Announces Annual Report 2018
Audit Report / Information FY 2018
2019-02-22 Danish